PREDICTIVE VALUE OF SEATTLE HEART FAILURE MODEL IN PATIENTS UNDERGOING TRANSCATHETER AORTIC VALVE REPLACEMENT

PREDICTIVE VALUE OF SEATTLE HEART FAILURE MODEL IN PATIENTS UNDERGOING TRANSCATHETER AORTIC VALVE REPLACEMENT

Background Seattle Heart Failure Model (SHFM) is a validated risk assessment tool in heart failure (HF) patients, but its utility for predicting survival in patients undergoing transcatheter aortic valve replacement (TAVR) remains to be evaluated. Use of beta-blockers was 68%, diuretics was 65%, ang...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American College of Cardiology 2018-03, Vol.71 (11), p.A1342-A1342
Hauptverfasser: Sinibaldi, Everett, Ramanan, Thammi, Sawant, Abhishek, Bhardwaj, Aishwarya, Hansen, Rosemary, Pham, Michael, Khalil, Charl, Sharma, Ashutosh, Kumar, Abhinav, Iyer, Vijay
Format: Artikel
Sprache:eng
Schlagworte:
Aortic valve
Cardiology
Diuretics
Heart diseases
Heart failure
Mortality
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page A1342
container_issue 11
container_start_page A1342
container_title Journal of the American College of Cardiology
container_volume 71
creator Sinibaldi, Everett
Ramanan, Thammi
Sawant, Abhishek
Bhardwaj, Aishwarya
Hansen, Rosemary
Pham, Michael
Khalil, Charl
Sharma, Ashutosh
Kumar, Abhinav
Iyer, Vijay
description Background Seattle Heart Failure Model (SHFM) is a validated risk assessment tool in heart failure (HF) patients, but its utility for predicting survival in patients undergoing transcatheter aortic valve replacement (TAVR) remains to be evaluated. Use of beta-blockers was 68%, diuretics was 65%, angiotensin converting enzyme inhibitors was 24%, aldosterone receptor blockers was 17%, and potassium-sparing diuretics was 7%.
doi_str_mv 10.1016/S0735-1097(18)31883-7
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2014438632</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0735109718318837</els_id><sourcerecordid>2014438632</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1302-a7111df08305338a09081de71769f88c3691c134c462456c86f3436bc5cdf96a3</originalsourceid><addsrcrecordid>eNqFkEFPgzAYhhujiXP6E0yaeNED2o9CKSfTsG4jYbBA2bXBUhIWtylsJv572Wa8eurleZ8vfRC6B_IMBNhLQQLqO0DC4BH4EwXOqRNcoBH4PneoHwaXaPSHXKObvl8TQhiHcIQ2y1xO4kjFK4lXIiklzqa4kEKpROK5FLnCUxEnZS7xIpvIBMcpXgoVy1QVuEwnMp9lcTrDKhdpEQk1l0rmWGS5iqOjcNDmcpmISC6GyS26aqr33t79vmNUTqWK5k6SzeJIJI4BSlynCgCgbginxKeUVyQkHGobQMDChnNDWQgD6RmPuZ7PDGcN9Sh7M76pm5BVdIwezt6Pbvd5sP1er3eHbjuc1C4Bz6OcUXeg_DNlul3fd7bRH127qbpvDUQfy-pTWX3MpoHrU1kdDLvX884OX_hqbad709qtsXXbWbPX9a79x_ADytF1Bg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2014438632</pqid></control><display><type>article</type><title>PREDICTIVE VALUE OF SEATTLE HEART FAILURE MODEL IN PATIENTS UNDERGOING TRANSCATHETER AORTIC VALVE REPLACEMENT</title><source>Elsevier ScienceDirect Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Sinibaldi, Everett ; Ramanan, Thammi ; Sawant, Abhishek ; Bhardwaj, Aishwarya ; Hansen, Rosemary ; Pham, Michael ; Khalil, Charl ; Sharma, Ashutosh ; Kumar, Abhinav ; Iyer, Vijay</creator><creatorcontrib>Sinibaldi, Everett ; Ramanan, Thammi ; Sawant, Abhishek ; Bhardwaj, Aishwarya ; Hansen, Rosemary ; Pham, Michael ; Khalil, Charl ; Sharma, Ashutosh ; Kumar, Abhinav ; Iyer, Vijay</creatorcontrib><description>Background Seattle Heart Failure Model (SHFM) is a validated risk assessment tool in heart failure (HF) patients, but its utility for predicting survival in patients undergoing transcatheter aortic valve replacement (TAVR) remains to be evaluated. Use of beta-blockers was 68%, diuretics was 65%, angiotensin converting enzyme inhibitors was 24%, aldosterone receptor blockers was 17%, and potassium-sparing diuretics was 7%.</description><identifier>ISSN: 0735-1097</identifier><identifier>EISSN: 1558-3597</identifier><identifier>DOI: 10.1016/S0735-1097(18)31883-7</identifier><language>eng</language><publisher>New York: Elsevier Inc</publisher><subject>Aortic valve ; Cardiology ; Diuretics ; Heart diseases ; Heart failure ; Mortality</subject><ispartof>Journal of the American College of Cardiology, 2018-03, Vol.71 (11), p.A1342-A1342</ispartof><rights>2018 American College of Cardiology Foundation</rights><rights>Copyright Elsevier Limited Mar 10, 2018</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/S0735-1097(18)31883-7$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,3536,27903,27904,45974</link.rule.ids></links><search><creatorcontrib>Sinibaldi, Everett</creatorcontrib><creatorcontrib>Ramanan, Thammi</creatorcontrib><creatorcontrib>Sawant, Abhishek</creatorcontrib><creatorcontrib>Bhardwaj, Aishwarya</creatorcontrib><creatorcontrib>Hansen, Rosemary</creatorcontrib><creatorcontrib>Pham, Michael</creatorcontrib><creatorcontrib>Khalil, Charl</creatorcontrib><creatorcontrib>Sharma, Ashutosh</creatorcontrib><creatorcontrib>Kumar, Abhinav</creatorcontrib><creatorcontrib>Iyer, Vijay</creatorcontrib><title>PREDICTIVE VALUE OF SEATTLE HEART FAILURE MODEL IN PATIENTS UNDERGOING TRANSCATHETER AORTIC VALVE REPLACEMENT</title><title>Journal of the American College of Cardiology</title><description>Background Seattle Heart Failure Model (SHFM) is a validated risk assessment tool in heart failure (HF) patients, but its utility for predicting survival in patients undergoing transcatheter aortic valve replacement (TAVR) remains to be evaluated. Use of beta-blockers was 68%, diuretics was 65%, angiotensin converting enzyme inhibitors was 24%, aldosterone receptor blockers was 17%, and potassium-sparing diuretics was 7%.</description><subject>Aortic valve</subject><subject>Cardiology</subject><subject>Diuretics</subject><subject>Heart diseases</subject><subject>Heart failure</subject><subject>Mortality</subject><issn>0735-1097</issn><issn>1558-3597</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNqFkEFPgzAYhhujiXP6E0yaeNED2o9CKSfTsG4jYbBA2bXBUhIWtylsJv572Wa8eurleZ8vfRC6B_IMBNhLQQLqO0DC4BH4EwXOqRNcoBH4PneoHwaXaPSHXKObvl8TQhiHcIQ2y1xO4kjFK4lXIiklzqa4kEKpROK5FLnCUxEnZS7xIpvIBMcpXgoVy1QVuEwnMp9lcTrDKhdpEQk1l0rmWGS5iqOjcNDmcpmISC6GyS26aqr33t79vmNUTqWK5k6SzeJIJI4BSlynCgCgbginxKeUVyQkHGobQMDChnNDWQgD6RmPuZ7PDGcN9Sh7M76pm5BVdIwezt6Pbvd5sP1er3eHbjuc1C4Bz6OcUXeg_DNlul3fd7bRH127qbpvDUQfy-pTWX3MpoHrU1kdDLvX884OX_hqbad709qtsXXbWbPX9a79x_ADytF1Bg</recordid><startdate>20180310</startdate><enddate>20180310</enddate><creator>Sinibaldi, Everett</creator><creator>Ramanan, Thammi</creator><creator>Sawant, Abhishek</creator><creator>Bhardwaj, Aishwarya</creator><creator>Hansen, Rosemary</creator><creator>Pham, Michael</creator><creator>Khalil, Charl</creator><creator>Sharma, Ashutosh</creator><creator>Kumar, Abhinav</creator><creator>Iyer, Vijay</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>6I.</scope><scope>AAFTH</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TK</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope></search><sort><creationdate>20180310</creationdate><title>PREDICTIVE VALUE OF SEATTLE HEART FAILURE MODEL IN PATIENTS UNDERGOING TRANSCATHETER AORTIC VALVE REPLACEMENT</title><author>Sinibaldi, Everett ; Ramanan, Thammi ; Sawant, Abhishek ; Bhardwaj, Aishwarya ; Hansen, Rosemary ; Pham, Michael ; Khalil, Charl ; Sharma, Ashutosh ; Kumar, Abhinav ; Iyer, Vijay</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1302-a7111df08305338a09081de71769f88c3691c134c462456c86f3436bc5cdf96a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Aortic valve</topic><topic>Cardiology</topic><topic>Diuretics</topic><topic>Heart diseases</topic><topic>Heart failure</topic><topic>Mortality</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sinibaldi, Everett</creatorcontrib><creatorcontrib>Ramanan, Thammi</creatorcontrib><creatorcontrib>Sawant, Abhishek</creatorcontrib><creatorcontrib>Bhardwaj, Aishwarya</creatorcontrib><creatorcontrib>Hansen, Rosemary</creatorcontrib><creatorcontrib>Pham, Michael</creatorcontrib><creatorcontrib>Khalil, Charl</creatorcontrib><creatorcontrib>Sharma, Ashutosh</creatorcontrib><creatorcontrib>Kumar, Abhinav</creatorcontrib><creatorcontrib>Iyer, Vijay</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><jtitle>Journal of the American College of Cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sinibaldi, Everett</au><au>Ramanan, Thammi</au><au>Sawant, Abhishek</au><au>Bhardwaj, Aishwarya</au><au>Hansen, Rosemary</au><au>Pham, Michael</au><au>Khalil, Charl</au><au>Sharma, Ashutosh</au><au>Kumar, Abhinav</au><au>Iyer, Vijay</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>PREDICTIVE VALUE OF SEATTLE HEART FAILURE MODEL IN PATIENTS UNDERGOING TRANSCATHETER AORTIC VALVE REPLACEMENT</atitle><jtitle>Journal of the American College of Cardiology</jtitle><date>2018-03-10</date><risdate>2018</risdate><volume>71</volume><issue>11</issue><spage>A1342</spage><epage>A1342</epage><pages>A1342-A1342</pages><issn>0735-1097</issn><eissn>1558-3597</eissn><abstract>Background Seattle Heart Failure Model (SHFM) is a validated risk assessment tool in heart failure (HF) patients, but its utility for predicting survival in patients undergoing transcatheter aortic valve replacement (TAVR) remains to be evaluated. Use of beta-blockers was 68%, diuretics was 65%, angiotensin converting enzyme inhibitors was 24%, aldosterone receptor blockers was 17%, and potassium-sparing diuretics was 7%.</abstract><cop>New York</cop><pub>Elsevier Inc</pub><doi>10.1016/S0735-1097(18)31883-7</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0735-1097
ispartof Journal of the American College of Cardiology, 2018-03, Vol.71 (11), p.A1342-A1342
issn 0735-1097
1558-3597
language eng
recordid cdi_proquest_journals_2014438632
source Elsevier ScienceDirect Journals; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects Aortic valve
Cardiology
Diuretics
Heart diseases
Heart failure
Mortality
title PREDICTIVE VALUE OF SEATTLE HEART FAILURE MODEL IN PATIENTS UNDERGOING TRANSCATHETER AORTIC VALVE REPLACEMENT
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T00%3A25%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=PREDICTIVE%20VALUE%20OF%20SEATTLE%20HEART%20FAILURE%20MODEL%20IN%20PATIENTS%20UNDERGOING%20TRANSCATHETER%20AORTIC%20VALVE%20REPLACEMENT&rft.jtitle=Journal%20of%20the%20American%20College%20of%20Cardiology&rft.au=Sinibaldi,%20Everett&rft.date=2018-03-10&rft.volume=71&rft.issue=11&rft.spage=A1342&rft.epage=A1342&rft.pages=A1342-A1342&rft.issn=0735-1097&rft.eissn=1558-3597&rft_id=info:doi/10.1016/S0735-1097(18)31883-7&rft_dat=%3Cproquest_cross%3E2014438632%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2014438632&rft_id=info:pmid/&rft_els_id=S0735109718318837&rfr_iscdi=true